BCL2L13 and myocardial infarction: Increased miR-96-5p would ameliorate acute myocardial infarction-associated cardiomyocytes injury by targeting BCL2L13, and miR-96-5p may function as a potential diagnostic biomarker for patients with coronary artery disease [22].